Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.

Sasha R Fehily Aysha H Al-Ani Jonathan AbdelmalakClarissa RentchEva ZhangJustin T DenholmDouglas JohnsonWilliam K K Wu Navneet Sharma David T RubinPeter R GibsonBritt Christensen

Published in: Alimentary pharmacology & therapeutics (2022)

Proactive screening for LTBI is essential in patients with IBD undergoing immune-suppressing therapy and several therapeutic strategies are available. Reporting of real-world experience is essential to refining current management recommendations.

Keyphrases

mycobacterium tuberculosis
adverse drug
signaling pathway
clinical practice
emergency department
human health